|
|
|
|
|
Legal status
Patent not validated
| (51) | INT.CL. | C07D 215/38 | |
| A61K 31/435 |
| (11) | Number of the document | 2325171 |
| (13) | Kind of document | T |
| (96) | European patent application number | 11155225.3 |
| Date of filing the European patent application | 2006-05-26 | |
| (97) | Date of publication of the European application | 2011-05-25 |
| (45) | Date of publication and mention of the grant of the patent | 2013-10-09 |
| (46) | Date of publication of the claims translation |
| (30) | Number | Date | Country code |
| 685460 P | 2005-05-26 | US | |
| 723577 P | 2005-10-04 | US |
| (72) |
Jordan, Thomas A, US
Dowling, John E., US
Chabala, John C., US
|
| (73) |
Aldexa Therapeutics, Inc.,
15 New England Executive Park, Burlington, MA 01803,
US
|
| (54) | Quinoline derivatives for treating retinal diseases |
| Quinoline derivatives for treating retinal diseases |